Neural Control and Cardiac-Vascular Function in Women With PTSD (VA Psychological Assessment)
1 other identifier
interventional
24
1 country
2
Brief Summary
The purpose of this research is 1) to investigate the role of the sympathetic nervous system and cardiac-vascular function in women with PTSD; and 2) to determine whether lifestyle modifications (exercise training and healthy eating) would be effective in reducing sympathetic activity, improving cardiovascular function, and improving psychiatric and quality of life outcomes in women with PTSD. It is hypothesized that (1) women with PTSD will have over-activation of the sympathetic nervous system and impaired cardiac-vascular function compared with women who are trauma free, and (2) lifestyle modifications can reduce sympathetic activity, improve cardiac-vascular function, and improve psychiatric symptoms and quality of life in women with PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2018
CompletedFirst Submitted
Initial submission to the registry
April 24, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedSeptember 30, 2022
September 1, 2022
10 months
April 24, 2019
September 28, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Muscle Sympathetic Nerve Activity (MSNA; Data collected by IEEM)
Muscle sympathetic nerve activity will be measured using microneurography at the peroneal nerve.
+PTSD vs. -PTSD baseline comparison; Changes from baseline following 12-week intervention
Clinician Administered Posttraumatic Stress Disorder Scale - 5 (CAPS-5; Data collected by VANTHCS)
CAPS-5 is a 30-item structured interview that corresponds to the DSM-5 diagnosis for PTSD. The instrument is used to make a current or lifetime diagnosis of PTSD, as well as assess symptom severity. Total symptom severity scores range from 0 to 80. A higher score indicates greater symptom severity. Individual symptom severity scores range from 0 (absent) to 4 (extreme/incapacitating) and are based on symptom frequency and intensity.
Changes from baseline following 12-week intervention
Secondary Outcomes (9)
PTSD Checklist for DSM-5 (PCL-5; Data collected by VANTHCS)
Changes from baseline through 12-week intervention
Quick Inventory for Depressive Symptomatology-self report (QIDS- SR16; Data collected by VANTHCS)
Changes from baseline through 12-week intervention
Concise Health Risk Tracking Scale - self-report module (CHRT; data collected by VANTHCS)
Changes from baseline through 12-week intervention
Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF; data collected by VANTHCS)
Changes from baseline through 12-week intervention
36-Item Short Form Health Survey (SF-36; Data collected by IEEM)
+PTSD vs. -PTSD baseline comparison; Changes from baseline following 12-week intervention
- +4 more secondary outcomes
Study Arms (2)
Lifestyle Modification Group
EXPERIMENTALControl Group
NO INTERVENTIONInterventions
Exercise Training: A "personalized" training program will be developed for participants. Based on maximal steady state heart rate and resting heart rate, three training zones (recovery, base pace, and maximal steady state) will be determined. The target heart rate for each training zone will be set for each patient. The majority of training sessions during the early phase of the program will be prescribed as "base pace" with target heart rate equivalent to about 75% of maximal. Initially, patients will train 3 times per week for 20-30 minutes per session by walking, jogging or swimming. As the patients become relatively fit, the duration of the base training sessions will be prolonged, and subsequently sessions of increased intensity (i.e., maximal steady state) will be added. Healthy Eating: Participants will be provided with dietary advice consistent with the American Heart Association guidelines (D.A.S.H. diet eating plan).
Eligibility Criteria
You may qualify if:
- Be either a female veteran with a current diagnosis of PTSD (for the PTSD group) or a female non-veteran without a current diagnosis of PTSD (for the non-PTSD control group).
- Be between the ages of 18-65.
- Sedentary (exercises less than three times a week for thirty minutes or less).
You may not qualify if:
- Any evidence of cardiopulmonary and neurological diseases by history or by physical examination.
- Chronic kidney disease (serum creatinine \> 1.5 mg/dL).
- Peripheral vascular disease.
- Peripheral neuropathy.
- Current substance use disorder other than tobacco related.
- Endurance-trained athletes due to the effects of exercise training on sympathetic neural control and cardiac-vascular function.
- Current pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- North Texas Veterans Healthcare Systemlead
- University of Texas Southwestern Medical Centercollaborator
- Texas Health Resourcescollaborator
Study Sites (2)
Dallas VA Medical Center
Dallas, Texas, 75216, United States
The Institute for Exercise and Environmental Medicine
Dallas, Texas, 75231, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geetha Shivakumar, MD, MS
Dallas VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 24, 2019
First Posted
April 29, 2019
Study Start
March 27, 2017
Primary Completion
January 9, 2018
Study Completion
January 9, 2018
Last Updated
September 30, 2022
Record last verified: 2022-09